OC
ASPX

Oppenheimer & Co’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Oppenheimer & Co’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-6,000
Closed -$602K – 1629
2015
Q1 		$602K Buy
+6,000
New +$400K 0.02% 797

Oppenheimer & Co's ASPX Position: Q2 2015 in Review

Oppenheimer & Co sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 6,000 shares — an estimated $602K sold.

Oppenheimer & Co first reported a position in ASPX in Q1 2015 and held it in 1 quarter. The position peaked at $602K in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Oppenheimer & Co reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Oppenheimer & Co sold 6,000 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $602K.
  • Oppenheimer & Co first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • Oppenheimer & Co's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $602K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Oppenheimer & Co's 13F filing for Q2 2015, filed 12 Aug 2015.